Sickle Cell Disease-Unanswered Questions and Future Directions in Therapy

Overview

Journal Semin Hematol

Specialty Hematology

Date 2018 Jul 1

PMID 29958561

Citations 2

Authors

Swee Lay Thein

John Tisdale

Affiliations

Soon will be listed here.

Citing Articles

Optimal disease management and health monitoring in adults with sickle cell disease.

Howard J, Thein S Hematology Am Soc Hematol Educ Program. 2019; 2019(1):505-512.

PMID: 31808832 PMC: 6913450. DOI: 10.1182/hematology.2019000055.

A Growing Population of Older Adults with Sickle Cell Disease.

Shet A, Thein S Clin Geriatr Med. 2019; 35(3):349-367.

PMID: 31230736 PMC: 10757270. DOI: 10.1016/j.cger.2019.03.006.

References

Telfer P, Coen P, Chakravorty S, Wilkey O, Evans J, Newell H . Clinical outcomes in children with sickle cell disease living in England: a neonatal cohort in East London. Haematologica. 2007; 92(7):905-12. DOI: 10.3324/haematol.10937. View

Telen M . Beyond hydroxyurea: new and old drugs in the pipeline for sickle cell disease. Blood. 2016; 127(7):810-9. PMC: 4760087. DOI: 10.1182/blood-2015-09-618553. View

McGann P, Hernandez A, Ware R . Sickle cell anemia in sub-Saharan Africa: advancing the clinical paradigm through partnerships and research. Blood. 2016; 129(2):155-161. PMC: 5234214. DOI: 10.1182/blood-2016-09-702324. View

Serjeant G, Chin N, Asnani M, Serjeant B, Mason K, Hambleton I . Causes of death and early life determinants of survival in homozygous sickle cell disease: The Jamaican cohort study from birth. PLoS One. 2018; 13(3):e0192710. PMC: 5832208. DOI: 10.1371/journal.pone.0192710. View

Canver M, Orkin S . Customizing the genome as therapy for the β-hemoglobinopathies. Blood. 2016; 127(21):2536-45. PMC: 4882803. DOI: 10.1182/blood-2016-01-678128. View

Mentzer W, Heller S, Pearle P, Hackney E, Vichinsky E . Availability of related donors for bone marrow transplantation in sickle cell anemia. Am J Pediatr Hematol Oncol. 1994; 16(1):27-9. View

Gluckman E, Cappelli B, Bernaudin F, Labopin M, Volt F, Carreras J . Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation. Blood. 2016; 129(11):1548-1556. PMC: 5356458. DOI: 10.1182/blood-2016-10-745711. View

Le P, Gulbis B, Dedeken L, Dupont S, Vanderfaeillie A, Heijmans C . Survival among children and adults with sickle cell disease in Belgium: Benefit from hydroxyurea treatment. Pediatr Blood Cancer. 2015; 62(11):1956-61. DOI: 10.1002/pbc.25608. View

Quinn C, Rogers Z, McCavit T, Buchanan G . Improved survival of children and adolescents with sickle cell disease. Blood. 2010; 115(17):3447-52. PMC: 2867259. DOI: 10.1182/blood-2009-07-233700. View

10.

Eaton W, Bunn H . Treating sickle cell disease by targeting HbS polymerization. Blood. 2017; 129(20):2719-2726. PMC: 5437829. DOI: 10.1182/blood-2017-02-765891. View

11.

Gardner K, Douiri A, Drasar E, Allman M, Mwirigi A, Awogbade M . Survival in adults with sickle cell disease in a high-income setting. Blood. 2016; 128(10):1436-8. DOI: 10.1182/blood-2016-05-716910. View

12.

Couque N, Girard D, Ducrocq R, Boizeau P, Haouari Z, Missud F . Improvement of medical care in a cohort of newborns with sickle-cell disease in North Paris: impact of national guidelines. Br J Haematol. 2016; 173(6):927-37. DOI: 10.1111/bjh.14015. View

13.

Hassell K . Population estimates of sickle cell disease in the U.S. Am J Prev Med. 2010; 38(4 Suppl):S512-21. DOI: 10.1016/j.amepre.2009.12.022. View

14.

Platt O, Brambilla D, Rosse W, Milner P, Castro O, Steinberg M . Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med. 1994; 330(23):1639-44. DOI: 10.1056/NEJM199406093302303. View

15.

Grosse S, Odame I, Atrash H, Amendah D, Piel F, Williams T . Sickle cell disease in Africa: a neglected cause of early childhood mortality. Am J Prev Med. 2011; 41(6 Suppl 4):S398-405. PMC: 3708126. DOI: 10.1016/j.amepre.2011.09.013. View

16.

Hsieh M, Fitzhugh C, Weitzel R, Link M, Coles W, Zhao X . Nonmyeloablative HLA-matched sibling allogeneic hematopoietic stem cell transplantation for severe sickle cell phenotype. JAMA. 2014; 312(1):48-56. PMC: 4698790. DOI: 10.1001/jama.2014.7192. View

17.

Elmariah H, Garrett M, De Castro L, Jonassaint J, Ataga K, Eckman J . Factors associated with survival in a contemporary adult sickle cell disease cohort. Am J Hematol. 2014; 89(5):530-5. PMC: 3988218. DOI: 10.1002/ajh.23683. View